Applied Dna Sciences Stock Analysis
APDN Stock | USD 0.24 5.56 95.86% |
Applied DNA Sciences is overvalued with Real Value of 0.28 and Target Price of 3.5. The main objective of Applied DNA stock analysis is to determine its intrinsic value, which is an estimate of what Applied DNA Sciences is worth, separate from its market price. There are two main types of Applied DNA's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Applied DNA's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Applied DNA's stock to identify patterns and trends that may indicate its future price movements.
The Applied DNA stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Applied DNA is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Applied Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Applied DNA's ongoing operational relationships across important fundamental and technical indicators.
Applied |
Applied Stock Analysis Notes
About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied DNA Sciences recorded a loss per share of 0.55. The entity last dividend was issued on the 1st of November 2019. The firm had 1:20 split on the 25th of April 2024. Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York. Applied Dna operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 78 people. For more info on Applied DNA Sciences please contact James Hayward at 631 240 8800 or go to https://www.adnas.com.Applied DNA Quarterly Total Revenue |
|
Applied DNA Sciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Applied DNA's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Applied DNA Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Applied DNA Sciences is way too risky over 90 days horizon | |
Applied DNA Sciences has some characteristics of a very speculative penny stock | |
Applied DNA Sciences appears to be risky and price may revert if volatility continues | |
Applied DNA Sciences has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 13.37 M. Net Loss for the year was (10.02 M) with profit before overhead, payroll, taxes, and interest of 5.05 M. | |
Applied DNA Sciences currently holds about 4.68 M in cash with (6.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 12.0% of the company shares are held by company insiders | |
Latest headline from seekingalpha.com: Applied DNA announces 1-for-20 reverse stock split |
Applied DNA Sciences Upcoming and Recent Events
Earnings reports are used by Applied DNA to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Applied DNA previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of February 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
5th of December 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
30th of September 2023 Last Financial Announcement | View |
Applied Largest EPS Surprises
Earnings surprises can significantly impact Applied DNA's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-05-12 | 2022-03-31 | -0.33 | -0.23 | 0.1 | 30 | ||
2021-05-13 | 2021-03-31 | -0.21 | -0.33 | -0.12 | 57 | ||
2021-08-12 | 2021-06-30 | -0.26 | -0.46 | -0.2 | 76 |
Applied Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Applied DNA is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Applied DNA Sciences backward and forwards among themselves. Applied DNA's institutional investor refers to the entity that pools money to purchase Applied DNA's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Hm Payson & Co | 2023-12-31 | 15.4 K | Natixis Sa | 2023-12-31 | 13.5 K | Creative Planning Inc | 2023-12-31 | 10.5 K | Wells Fargo & Co | 2023-12-31 | 2.9 K | Cutler Group Lp | 2023-12-31 | 2.8 K | Tower Research Capital Llc | 2023-12-31 | 2.3 K | Royal Bank Of Canada | 2023-12-31 | 1.7 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 656 | Bank Of America Corp | 2023-12-31 | 341 | Vanguard Group Inc | 2023-12-31 | 523.7 K | Amh Equity Ltd | 2023-12-31 | 370 K |
Applied Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Applied DNA's market, we take the total number of its shares issued and multiply it by Applied DNA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Applied Profitablity
Applied DNA's profitability indicators refer to fundamental financial ratios that showcase Applied DNA's ability to generate income relative to its revenue or operating costs. If, let's say, Applied DNA is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Applied DNA's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Applied DNA's profitability requires more research than a typical breakdown of Applied DNA's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.8) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.25. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (63.57) | (66.75) | |
Return On Capital Employed | (63.57) | (60.39) | |
Return On Assets | (63.57) | (60.39) | |
Return On Equity | (63.57) | (60.39) |
Management Efficiency
Applied DNA Sciences has return on total asset (ROA) of (0.5596) % which means that it has lost $0.5596 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1002) %, meaning that it created substantial loss on money invested by shareholders. Applied DNA's management efficiency ratios could be used to measure how well Applied DNA manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of April 2024, Return On Tangible Assets is likely to drop to -66.75. In addition to that, Return On Capital Employed is likely to grow to -60.39. At this time, Applied DNA's Asset Turnover is very stable compared to the past year.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.11 | 0.12 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 0.11 | 0.12 | |
Enterprise Value Over EBITDA | (906.70) | (861.36) | |
Price Book Value Ratio | (308.65) | (293.22) | |
Enterprise Value Multiple | (906.70) | (861.36) | |
Price Fair Value | (308.65) | (293.22) | |
Enterprise Value | 11.4 M | 10.8 M |
The analysis of Applied DNA's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Applied DNA's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Applied Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.094 |
Technical Drivers
As of the 24th of April, Applied DNA shows the Risk Adjusted Performance of (0.10), standard deviation of 5.34, and Mean Deviation of 3.54. Applied DNA Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down thirteen technical drivers for Applied DNA Sciences, which can be compared to its peers. Please confirm Applied DNA Sciences variance and value at risk to decide if Applied DNA Sciences is priced correctly, providing market reflects its regular price of 0.24 per share. As Applied DNA Sciences appears to be a penny stock we also recommend to validate its jensen alpha numbers.Applied DNA Sciences Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Applied DNA middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Applied DNA Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Applied DNA Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied DNA insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied DNA's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Applied DNA insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Judith Murrah over a month ago Acquisition by Judith Murrah of 150000 shares of Applied DNA subject to Rule 16b-3 | ||
Yacov Shamash over two months ago Applied DNA exotic insider transaction detected | ||
Schmalz Elizabeth M over a year ago Acquisition by Schmalz Elizabeth M of 75099 shares of Applied DNA subject to Rule 16b-3 |
Applied DNA Predictive Daily Indicators
Applied DNA intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Applied DNA stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 261680.0 | |||
Daily Balance Of Power | (92.67) | |||
Rate Of Daily Change | 0.0414 | |||
Day Median Price | 0.25 | |||
Day Typical Price | 0.25 | |||
Price Action Indicator | (2.79) | |||
Period Momentum Indicator | (5.56) | |||
Relative Strength Index | 47.4 |
Applied DNA Forecast Models
Applied DNA's time-series forecasting models are one of many Applied DNA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Applied DNA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Applied Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Applied DNA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Applied shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Applied DNA. By using and applying Applied Stock analysis, traders can create a robust methodology for identifying Applied entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.67) | (0.71) | |
Operating Profit Margin | (0.74) | (0.77) | |
Net Loss | (0.67) | (0.70) | |
Gross Profit Margin | 0.48 | 0.72 |
Current Applied Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Applied analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Applied analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
3.5 | Buy | 2 | Odds |
Most Applied analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Applied stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Applied DNA Sciences, talking to its executives and customers, or listening to Applied conference calls.
Applied Stock Analysis Indicators
Applied DNA Sciences stock analysis indicators help investors evaluate how Applied DNA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Applied DNA shares will generate the highest return on investment. By understating and applying Applied DNA stock analysis, traders can identify Applied DNA position entry and exit signals to maximize returns.
Begin Period Cash Flow | 15.2 M | |
Common Stock Shares Outstanding | 13.1 M | |
Total Stockholder Equity | 5 M | |
Property Plant And Equipment Net | 2.1 M | |
Cash And Short Term Investments | 7.2 M | |
Cash | 7.2 M | |
Accounts Payable | 1.1 M | |
Net Debt | -5.9 M | |
50 Day M A | 0.4815 | |
Total Current Liabilities | 2.8 M | |
Other Operating Expenses | 24.3 M | |
Non Current Assets Total | 5.5 M | |
Non Currrent Assets Other | 750 K | |
Stock Based Compensation | 1 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Applied DNA Sciences information on this page should be used as a complementary analysis to other Applied DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Applied Stock analysis
When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Stocks Directory Find actively traded stocks across global markets |
Is Applied DNA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.678 | Quarterly Revenue Growth (0.83) | Return On Assets (0.56) | Return On Equity (1.10) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.